The proprotein convertase SKI-1/S1P is a critical host factor for Nairobi sheep disease virus infectivity.
CCHFV
Glycoprotein proteolytic processing
Host cell factor
Infectivity
Nairobi sheep disease virus
Orthonairovirus
Journal
Virus research
ISSN: 1872-7492
Titre abrégé: Virus Res
Pays: Netherlands
ID NLM: 8410979
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
05
01
2023
revised:
14
03
2023
accepted:
18
03
2023
medline:
18
4
2023
pubmed:
23
3
2023
entrez:
22
3
2023
Statut:
ppublish
Résumé
Nairobi sheep disease virus (NSDV) belongs to the Orthonairovirus genus in the Bunyavirales order and is genetically related to human-pathogenic Crimean-Congo hemorrhagic fever virus (CCHFV). NSDV is a zoonotic pathogen transmitted by ticks and primarily affects naïve small ruminants in which infection leads to severe and often fatal hemorrhagic gastroenteritis. Despite its veterinary importance and the striking similarities in the clinical picture between NSDV-infected ruminants and CCHFV patients, the molecular pathogenesis of NSDV and its interactions with the host cell are largely unknown. Here, we identify the membrane-bound proprotein convertase site-1 protease (S1P), also known as subtilisin/kexin-isozyme-1 (SKI-1), as a host factor affecting NSDV infectivity. Absence of S1P in SRD-12B cells, a clonal CHO-K1 cell variant with a genetic defect in the S1P gene (MBTPS1), results in significantly decreased NSDV infectivity while transient complementation of SKI-1/S1P rescues NSDV infection. SKI-1/S1P is dispensable for virus uptake but critically required for production of infectious virus progeny. Moreover, we provide evidence that SKI-1/S1P is involved in the posttranslational processing of the NSDV glycoprotein precursor. Our results demonstrate the role of SKI-1/S1P in the virus life cycle of NSDV and suggest that this protease is a common host factor for orthonairoviruses and may thus represent a promising broadly-effective, indirect antiviral target.
Identifiants
pubmed: 36948228
pii: S0168-1702(23)00061-8
doi: 10.1016/j.virusres.2023.199099
pmc: PMC10194167
pii:
doi:
Substances chimiques
membrane-bound transcription factor peptidase, site 1
EC 3.4.21.112
Proprotein Convertases
EC 3.4.21.-
Glycoproteins
0
Serine Endopeptidases
EC 3.4.21.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
199099Subventions
Organisme : CIHR
ID : 148363
Pays : Canada
Informations de copyright
Copyright © 2023. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Adv Exp Med Biol. 2013;790:95-127
pubmed: 23884588
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12701-5
pubmed: 11606739
J Virol. 2003 Aug;77(16):8640-9
pubmed: 12885882
Adv Virus Res. 2017;98:83-118
pubmed: 28433053
Viruses. 2016 Feb 10;8(2):
pubmed: 26875984
Curr Opin Virol. 2013 Feb;3(1):3-12
pubmed: 23352692
Vet Res. 2012 Oct 19;43:71
pubmed: 23083136
Viruses. 2021 Jun 25;13(7):
pubmed: 34202098
Viruses. 2016 Jun 10;8(6):
pubmed: 27294949
Parassitologia. 1997 Jun;39(2):95-8
pubmed: 9530691
Viruses. 2021 Jun 27;13(7):
pubmed: 34199054
J Virol. 2002 Jul;76(14):7263-75
pubmed: 12072526
J Virol. 2011 Jan;85(2):795-803
pubmed: 21068251
Antiviral Res. 2021 Aug;192:105121
pubmed: 34175321
Mol Cell. 1998 Oct;2(4):505-14
pubmed: 9809072
Nat Rev Drug Discov. 2012 May;11(5):367-83
pubmed: 22679642
J Biol Chem. 1998 Oct 23;273(43):28261-9
pubmed: 9774448
J Virol. 2007 Dec;81(23):13271-6
pubmed: 17898072
J Virol. 2006 Jan;80(1):514-25
pubmed: 16352575
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1321-6
pubmed: 9990022
Viruses. 2021 Feb 23;13(2):
pubmed: 33672327
J Virol. 2008 Jun;82(12):6045-51
pubmed: 18400865
Cell. 1997 May 2;89(3):331-40
pubmed: 9150132
Viruses. 2016 Apr 21;8(4):106
pubmed: 27110812
J Pharmacol Exp Ther. 2008 Sep;326(3):801-8
pubmed: 18577702
PLoS One. 2017 Mar 24;12(3):e0174483
pubmed: 28339489
Front Vet Sci. 2020 Jul 22;7:419
pubmed: 32793646
Virology. 2003 Sep 15;314(1):168-78
pubmed: 14517070
Antiviral Res. 2012 Aug;95(2):159-66
pubmed: 22626636
Virology. 2002 Nov 10;303(1):146-51
pubmed: 12482666
PLoS Pathog. 2012 Jan;8(1):e1002468
pubmed: 22241994
J Biol Chem. 2006 Aug 18;281(33):23471-81
pubmed: 16790437
PLoS Pathog. 2020 Sep 21;16(9):e1008850
pubmed: 32956404
mBio. 2015 Jun 30;6(4):e00801
pubmed: 26126854
Bioorg Med Chem Lett. 2007 Aug 15;17(16):4411-4
pubmed: 17583500
Rev Sci Tech. 2015 Aug;34(2):411-7
pubmed: 26647464
Virology. 2015 Aug;482:19-27
pubmed: 25817401
J Virol. 2000 Dec;74(23):11418-21
pubmed: 11070044
J Virol. 2003 Mar;77(5):2866-72
pubmed: 12584310
J Virol. 2010 Apr;84(7):3178-88
pubmed: 20071570
Virology. 2012 Feb 5;423(1):14-22
pubmed: 22154237
Viruses. 2016 May 24;8(5):
pubmed: 27213430